Atopic Dermatitis Clinical Trials in Ann Arbor, Michigan

4 studies are recruiting for atopic dermatitis in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

    The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. …

    Stage
    Not phased
    Ages
    12 and older
    Site
    David Fivenson, MD, Dermatology, PLLC- Site Number : 8400017, Ann Arbor, Michigan
    Locations
    79 in total
    Run by
    Sanofi

    See if you can join NCT07290803 on ClinicalTrials.gov

  2. Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project

    This study will explore potential links between atopic dermatitis and food allergy. This information will be useful to determine atopic dermatitis and food allergy share unique biochemical or genetic identifiers useful for diagnosing and treatments in the future. This is a mechanistic study consist…

    Stage
    Not phased
    Ages
    10 to 55
    Site
    University of Michigan, Ann Arbor, Michigan
    Run by
    University of Michigan

    See if you can join NCT06300697 on ClinicalTrials.gov

  3. Ethnic Differences in Mechanisms of Action of Dupilumab

    Previous research has shown that Asian and African Americans are more likely to develop atopic dermatitis (AD) than their Caucasian counterparts. However, limited information is known about AD in Asian and African American populations because most molecular studies have focused on Caucasians with A…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    University of Michigan, Ann Arbor, Michigan
    Run by
    University of Michigan

    See if you can join NCT05268107 on ClinicalTrials.gov

  4. A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

    Hidradenitis suppurativa (HS) and atopic dermatitis (AD) are chronic inflammatory skin diseases that lead to the development of skin lesions and symptoms such as pain and discomfort. The purpose of this study is to assess molecular changes in adult participants with moderate to severe HS or with mo…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    University of Michigan Health System - Ann Arbor /ID# 267275, Ann Arbor, Michigan
    Locations
    2 in total
    Run by
    AbbVie

    See if you can join NCT06524635 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.